GlassScriptPhysician profile
Michael Charles Bateman
NPI 1871675314
$12,683.29
in general payments reported to CMS, 2019-2025
25 companies · $4,204 in 2025
The $4,204 reported for 2025 was more than what 91% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $761 · 2020: $401 · 2021: $834 · 2022: $1,370 · 2023: $2,519 · 2024: $2,596 · 2025: $4,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,784 · Honoraria: $2,400 · Travel and Lodging: $2,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,784.26 |
| Honoraria | $2,400.00 |
| Travel and Lodging | $2,133.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $2,430.02 | 2022-2025 | |
| Musculoskeletal Transplant Foundation INC. | $2,404.67 | 2022-2025 | |
| Axogen | $2,239.76 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Sientra, INC. | $1,140.14 | 2019-2022 | |
| Abbvie INC. | $999.53 | 2023-2025 | Alloderm |
| Allergan, INC. | $924.73 | 2019-2022 | |
| Shockwave Medical, INC | $707.15 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Motiva USA, LLC | $459.94 | 2025 | |
| Integra Lifesciences Corporation | $380.73 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Mentor Worldwide LLC | $335.56 | 2019-2025 | Mentor Cpx 4 Breast Tissue Expander |
| Stryker Corporation | $183.47 | 2019-2021 | |
| Surgalign Spine Technologies, INC. | $61.23 | 2019-2020 | |
| Revance Therapeutics, INC. | $58.65 | 2025 | Daxxify |
| Davol INC. | $58.15 | 2023 | Phasix Mesh |
| Glaxosmithkline, LLC. | $45.43 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $38.76 | 2024-2025 | V.A.C.Ulta, Prevena |
| Merz North America, INC. | $36.96 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $32.22 | 2025 | |
| Tela Bio, INC. | $27.45 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Galderma Laboratories, L.P. | $26.73 | 2025 | |
| Innovation Technologies INC | $24.68 | 2023 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $18.65 | 2023 | Exparel |
| Ethicon US, LLC | $18.51 | 2024 | Stratafix |
| Conmed Corporation | $15.35 | 2023 | Visiclear |
| Lemaitre Vascular, INC. | $14.82 | 2023 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bateman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.